US Healthcare Expense Trends Are Shifting Fast-why?
- 01. US healthcare expense trends are shifting fast-why?
- 02. Big picture: where spending is going
- 03. Drivers of accelerating costs
- 04. Key segments and their growth rates
- 05. Drug spending and specialty medications
- 06. Enrollment and payer-mix shifts
- 07. Year-by-year snapshot of US healthcare costs
- 08. Employers, insurers, and household burdens
- 09. Policy and structural pressures ahead
- 10. Why costs are shifting so fast
- 11. What stakeholders can realistically expect
US healthcare expense trends are shifting fast-why?
In 2024, US healthcare spending surged to roughly $5.3 trillion, or about $15,500 per person, representing 18.0% of GDP and growing at about 7-7.5% annually since 2022 after a brief pandemic-driven spike above 10% in 2020. This acceleration reflects a structural shift: higher health insurance enrollment, stronger utilization of services, and rising prescription drug prices, particularly for chronic-disease therapies, rather than a single temporary shock.
Big picture: where spending is going
National health spending has climbed from about $4.5 trillion in 2022 to $5.3 trillion in 2024, with the sector's share of GDP edging up from 17.3% to 18.0% over the same period. That implies an average annual growth rate of roughly 7-8% in nominal dollars, well above the typical 2-3% real GDP growth runway, which tightens pressure on federal budgets, employer health insurance premiums, and household out-of-pocket costs.
Three categories dominate the spending surge: hospital care, physician and clinical services, and retail prescription drugs. In 2024, hospital spending reached about $1.6 trillion (up 8.9%), physician and clinical services about $1.1 trillion (up 8.1%), and retail prescription drugs $467 billion (up 7.9%), together accounting for roughly 61% of total national health expenditures.
Drivers of accelerating costs
Two main forces are pushing US healthcare expense trends upward: volume and price. After the initial pandemic wave, hospital utilization has rebounded, with higher patient acuity and more complex cases driving both volume and intensity per episode of care. At the same time, prescription drug prices-especially for newer diabetes, obesity, and specialty therapies-have climbed double-digits in some categories, amplifying the impact of each filled script.
On the coverage side, the share of Americans with health insurance coverage has reached historic highs, hovering near 92-93% as of 2023-2024. More insured patients translate into higher use of services that were previously rationed or deferred, particularly outpatient visits and elective procedures, which in turn feeds the growth in personal health care spending.
Key segments and their growth rates
Hospital care has been the fastest-growing major category over the past three years. In 2023, hospital spending grew 10.4% on the back of post-pandemic volume rebounds and higher case mix, while 2024 saw a still-robust 8.9% increase even as hospital price growth itself accelerated to 3.4%-the highest rate since 2007. That divergence suggests that both more admissions and higher charges per admission are inflating the hospital services bill.
Physician and clinical services have also expanded quickly, with 7-8% annual growth since 2022. In 2023, physician services rose 7.6% and clinical services 7.0%, driven by higher visit volumes and more frequent imaging and lab testing per encounter. By 2024, these categories together hit about 21% of national spending, reflecting the centrality of ambulatory care in the modern cost structure.
Drug spending and specialty medications
Spending on prescription drugs has consistently outpaced overall health-spending growth, with about 5.7-11.4% annual increases over the 2020-2024 window depending on the year and data source. In 2023, retail drug spending jumped 11.4%, largely due to fast-rising demand for medications treating chronic diseases such as diabetes and obesity, which now account for a much larger share of total drug costs than a decade ago.
By 2024, retail prescription drugs reached $467 billion, or roughly 9% of national health spending, with prices for certain specialty drugs rising near or above 10% annually. Analysts note that newer weight-loss and diabetes GLP-1 agents, many priced above $10,000 per year per patient, are now responsible for a meaningful slice of the total drug budget, further straining employer-sponsored plans and Medicare Part D formularies.
Enrollment and payer-mix shifts
Increased health insurance enrollment has been a quiet engine of spending growth since 2021. The insured share of the population reached about 92% in 2Consider 2022 and edged up to roughly 92.5-93% by 2023, as Medicaid expansion and subsidies under the Affordable Care Act expanded coverage. Enrollment in ACA marketplace plans rose more than 30% between 2023 and 2024, reaching about 21.1 million people, while total private health insurance coverage topped 214 million individuals.
That coverage expansion has reshaped the payer mix across providers. Hospitals and physician groups now see a larger share of claims flowing through private insurers and Medicare Advantage, which often negotiate higher reimbursement rates than traditional Medicaid, thus lifting aggregate revenue per patient even as volume normalizes post-pandemic. CMS actuaries note that this "full-employment" environment for services-combined with still-elevated prices-explains why personal health care spending grew about 8.9% in 2024, the fastest pace since the early 1990s.
Year-by-year snapshot of US healthcare costs
The table below illustrates the trajectory of US healthcare expense trends from 2020 through 2024, using CMS-style estimates and rounded figures for clarity.
| Year | Total Spending (US$ trillions) | Growth Rate | Share of GDP (%) | Per Capita (approx.) |
|---|---|---|---|---|
| 2020 | 4.1 | 10.4% | 19.5% | $12,500 |
| 2021 | 4.3 | 4.2% | 18.3% | $12,900 |
| 2022 | 4.5 | 4.6% | 17.3% | $13,500 |
| 2023 | 4.9 | 7.5% | 17.6% | $14,600 |
| 2024 | 5.3 | 7.2% | 18.0% | $15,500 |
This progression underscores that the current spending acceleration is not a one-off blip but a multi-year escalator, with the 2023-2024 run-rate of 7-7.5% growth occurring against a backdrop of only 2-3% real GDP expansion.
Employers, insurers, and household burdens
As employer-sponsored health insurance carries a larger slice of total national health expenditures, plan sponsors are responding with rising premiums, higher deductibles, and more aggressive prior-authorization rules. Brokers and actuaries estimate that large-employer group medical premiums increased about 5-7% annually in 2023-2024, with pharmacy benefit costs-especially for specialty drugs-often growing even faster.
For households, the burden of out-of-pocket healthcare costs has also risen, even as more people are insured. Deductibles and coinsurance for hospital stays and specialty drug regimens can easily exceed thousands of dollars per year, and many families now allocate 10-15% of their income to premiums and uncovered medical expenses. CMS and policy analysts warn that such a trajectory is unsustainable if healthcare spending growth continues to outpace wage growth over the next decade.
Policy and structural pressures ahead
Federal and state policymakers are grappling with three competing priorities tied to healthcare expense trends: maintaining coverage gains, controlling Medicare and Medicaid costs, and moderating private-plan premiums. Recent legislative and regulatory moves include tighter drug-pricing rules, expanded Medicare Drug Price Negotiation, and renewed scrutiny of hospital consolidation and vertical integration, all aimed at dampening the upward trajectory of hospital pricing and drug outlays.
At the same time, CMS projects that national health spending will grow around 6-7% annually through 2027 under current law, implying that the sector could exceed $6 trillion by the end of the decade. That projection assumes continued growth in chronic disease prevalence, sustained demand for cutting-edge therapies, and only modest success in bending the cost curve through payment reform and care-coordination initiatives.
Why costs are shifting so fast
Several interlocking factors explain why US healthcare expense trends are shifting faster now than they were in the 2010s. First, population aging and rising rates of chronic and metabolic diseases are increasing the number of high-cost patients, even as per-capita utilization per episode rises due to more advanced diagnostics and treatments.
Second, the post-pandemic "catch-up" phase in elective and deferred care has temporarily compressed years of postponed procedures into a two- to three-year window, amplifying the volume effect. Third, technological innovation-especially in oncology, gene therapies, and metabolic drugs-brings high upfront prices even when long-term value is uncertain, creating a classic tension between innovation and affordability in the US health system.
What stakeholders can realistically expect
For employers, insurers, and policymakers, the takeaway is that healthcare spending growth is unlikely to return to the 2-3% annual range seen in the immediate post-Affordable Care Act years. Structural drivers-aging, technology, and chronic-disease burden-point toward a "new normal" of roughly 5-7% nominal growth, with periodic spikes when utilization rebounds or new high-cost therapies enter the market.
Providers, meanwhile, operate in a value-based care environment that nominally rewards efficiency but is still dominated by fee-for-service incentives for many services. Until payment reform meaningfully aligns financial incentives with outcomes and true total-cost management, there will be limited dampening effect on the overall trajectory of US healthcare expense trends.
Everything you need to know about Us Healthcare Expense Trends
Are US healthcare costs still rising?
Yes. US healthcare spending grew about 7% in 2024, hitting $5.3 trillion, and is projected to continue growing in the 5-7% range annually through at least 2027, according to CMS and health-policy analysts. This growth is broad-based across hospital care, physician services, and prescription drugs, indicating that the cost creep is structural rather than a one-off event.
What is driving the rise in US healthcare expenses?
The main drivers of rising US healthcare expenses are higher utilization of services, especially hospital and outpatient care, alongside rising prices for hospital stays and prescription drugs. Additional factors include an aging population, higher prevalence of chronic diseases, and nearly record-high rates of health insurance coverage, which increase access and therefore use of care.
How much does the average American spend on healthcare?
In 2024, average per-capita healthcare spending in the United States was about $15,500, or roughly 18% of GDP. This figure includes all public and private spending on hospital care, physician services, drugs, and administration, not just what individuals pay out of pocket.
Is hospital spending growing faster than other categories?
Yes. Hospital care has grown faster than many other segments, increasing about 8.9-10.4% annually in 2023-2024, compared with roughly 7-8% for physician and clinical services and 7-11% for prescription drugs depending on the year. That makes hospital services the largest single category of national health expenditures, accounting for just under one third of total spending.
What is the outlook for US healthcare costs over the next decade?
CMS and independent analysts project that US healthcare spending will continue to grow at about 5-7% per year, with the sector's share of GDP edging toward 18-19% by the late 2020s. Unless major reforms to payment models, drug pricing, and hospital consolidation are implemented, this trajectory implies that the total cost of personal health care could exceed $6 trillion within the next decade.